Ablation of SYK Kinase from Expanded Primary Human NK Cells via CRISPR/Cas9 Enhances Cytotoxicity and Cytokine Production
The Journal of Immunology · 2023
DOI: 10.4049/jimmunol.2200488 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2023. Verfasst von James D Dahlvang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Disease and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN. Hauptthemen laut MEDLINE: Cytomegalovirus, Cytomegalovirus Infections. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
CMV infection alters NK cell phenotype and function toward a more memory-like immune state. These cells, termed adaptive NK cells, typically express CD57 and NKG2C but lack expression of the FcRγ-chain (gene: FCER1G, FcRγ), PLZF, and SYK. Functionally, adaptive NK cells display enhanced Ab-dependent cellular cytotoxicity (ADCC) and cytokine production. However, the mechanism behind this enhanced function is unknown. To understand what drives enhanced ADCC and cytokine production in adaptive NK cells, we optimized a CRISPR/Cas9 system to ablate genes from primary human NK cells. We ablated genes that encode molecules in the ADCC pathway, such as FcRγ, CD3ζ, SYK, SHP-1, ZAP70, and the transcription factor PLZF, and tested subsequent ADCC and cytokine production. We found that ablating the FcRγ-chain caused a modest increase in TNF-α production. Ablation of PLZF did not enhance ADCC or cytokine production. Importantly, SYK kinase ablation significantly enhanced cytotoxicity, cytokine production, and target cell conjugation, whereas ZAP70 kinase ablation diminished function. Ablating the phosphatase SHP-1 enhanced cytotoxicity but reduced cytokine production. These results indicate that the enhanced cytotoxicity and cytokine production of CMV-induced adaptive NK cells is more likely due to the loss of SYK than the lack of FcRγ or PLZF. We found the lack of SYK expression could improve target cell conjugation through enhanced CD2 expression or limit SHP-1–mediated inhibition of CD16A signaling, leading to enhanced cytotoxicity and cytokine production.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Infectious Disease and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN.
- Center for Immunology, University of Minnesota, Minneapolis, MN.
- Masonic Cancer Center, University of Minnesota, Minneapolis, MN.
- Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN.
- Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN.
- Department of Veterinary and Biological Sciences, University of Minnesota, St. Paul, MN.
ORCID-Profile: James D Dahlvang, Jenna K Dick, Jules A Sangala, Philippa R Kennedy, Emily J Pomeroy, Juliette M Moushon, Claire E Thefaine, Jianming Wu, Sara E Hamilton, Martin Felices, Jeffrey S Miller, Bruce Walcheck, Geoffrey T Hart
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
- U.S. Department of Defense
Zitieren
APA
Dahlvang, J. D., Dick, J. K., Sangala, J. A., Kennedy, P. R., Pomeroy, E. J., Snyder, K. M., Moushon, J. M., Thefaine, C. E., Wu, J., Hamilton, S. E., Felices, M., Miller, J. S., Walcheck, B., Webber, B. R., Moriarity, B. S., & Hart, G. T. (2023). Ablation of SYK Kinase from Expanded Primary Human NK Cells via CRISPR/Cas9 Enhances Cytotoxicity and Cytokine Production. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2200488
Vancouver
Dahlvang JD, Dick JK, Sangala JA, Kennedy PR, Pomeroy EJ, Snyder KM, et al. Ablation of SYK Kinase from Expanded Primary Human NK Cells via CRISPR/Cas9 Enhances Cytotoxicity and Cytokine Production. The Journal of Immunology. 2023. doi:10.4049/jimmunol.2200488
BibTeX
@article{Dahlvang2023,
author = {Dahlvang, James D and Dick, Jenna K and Sangala, Jules A and Kennedy, Philippa R and Pomeroy, Emily J and Snyder, Kristin M and Moushon, Juliette M and Thefaine, Claire E and Wu, Jianming and Hamilton, Sara E and Felices, Martin and Miller, Jeffrey S and Walcheck, Bruce and Webber, Beau R and Moriarity, Branden S and Hart, Geoffrey T},
title = {Ablation of SYK Kinase from Expanded Primary Human NK Cells via CRISPR/Cas9 Enhances Cytotoxicity and Cytokine Production},
journal = {The Journal of Immunology},
year = {2023},
doi = {10.4049/jimmunol.2200488}
}
EUVIMED